middle.news
Nexsen Launches Clinical Trial for StrepSure® GBS Sensor, Eyeing 2026 Market Entry
9:09am on Tuesday 21st of October, 2025 AEDT
•
Healthcare
Read Story
Nexsen Launches Clinical Trial for StrepSure® GBS Sensor, Eyeing 2026 Market Entry
9:09am on Tuesday 21st of October, 2025 AEDT
Key Points
Clinical trial underway at Northern Hospital, Victoria
Device targets rapid detection of Group B Streptococcus in expectant mothers
Led by renowned maternal-fetal medicine expert Prof. Lisa Hui
Potential market launch and regulatory approvals targeted for 2H 2026
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Nexsen (ASX:NXN)
OPEN ARTICLE